Form 4: Novanta CFO Robert Buckley Executes Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Robert Buckley, CFO of Novanta Inc., exercised stock options and sold shares of common stock on July 1, 2024, under a pre-established Rule 10b5-1 trading plan.
Summary
- On July 1, 2024, Robert Buckley, the Chief Financial Officer of Novanta Inc., executed a stock option and sold shares of the company's common stock.
- The transactions were carried out under a pre-established Rule 10b5-1 trading plan adopted on March 12, 2024.
- Buckley exercised options to acquire 1,830 shares at a price of $14.13 per share.
- He then sold 1,013 shares at a weighted-average price of $160.44, 594 shares at $161.53, and 223 shares at $162.83.
- Following these transactions, Buckley directly owns 120,419 shares of Novanta Inc. common stock and 42,081 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to pre-planned stock sales by an executive. The existence of a 10b5-1 plan suggests a structured approach to avoid insider trading concerns.
Positives
- The transactions were executed under a pre-established Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, although the pre-planned nature of these sales mitigates this risk.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, and are usually not significant unless they represent a large percentage of the executive's holdings.
Comparison to Industry Standards
- Executive compensation practices, including stock options and trading plans, are common across publicly traded companies.
- Companies like Cognex, IPG Photonics, and MKS Instruments, which operate in similar technology sectors, also utilize stock-based compensation for their executives.
Stakeholder Impact
- The transactions are unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors, given the relatively small volume of shares sold and the pre-planned nature of the sales.
Key Dates
| Date | Description |
|---|---|
| 03/30/2017 | First vesting date of the Stock Options. |
| 03/30/2018 | Second vesting date of the Stock Options. |
| 03/30/2019 | Third vesting date of the Stock Options. |
| 03/12/2024 | Date the Rule 10b5-1 trading plan was adopted. |
| 07/01/2024 | Date of the stock option exercise and share sales. |
| 03/30/2026 | Expiration date of the Stock Options. |
| 07/03/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.